Surgery may spur rise in heart deaths after cancer diagnosis: study

October 17, 2012 by Randy Dotinga, Healthday Reporter
Surgery may spur rise in heart deaths after cancer diagnosis: study
Suggests that stress may not be the culprit behind the phenomenon.

(HealthDay)—New research suggests that surgical procedures, not stress, may lead to the spike in heart-related deaths known to occur in the weeks after a cancer diagnosis.

This new study theorizes that surgery involved in diagnosing and/or treating the cancer causes or contributes to the increased risk of heart-related deaths shortly after cancer is identified.

The researchers were skeptical about the widely held psychological-stress theory and launched an investigation to see whether surgery might lie behind the rise in . Previous research had shown that the risk of such as heart attacks rises after surgery, even low-risk operations, said report lead author Dr. Mark Voskoboynik, a medical oncology fellow at Peter MacCallum Cancer Center in Australia.

"Our analysis of a large database showed that death from cardiac causes was more common in patients that had surgery for their primary tumor compared to patients that did not undergo surgery," he said. The rate of death was doubled in the , their research showed.

The database included nearly 288,000 patients in the United States who were diagnosed with cancer from 1998 to 2008 and died within four weeks of the diagnosis.

Of these deceased , the researchers estimate that 12 percent who had surgery died of cardiac problems, compared to 6 percent of those who didn't undergo an operation.

Surgery "probably has an effect on the rates of early cardiovascular deaths among these patients, possibly over and above any influence of psychological stress," the authors wrote.

Their findings appear in a letter to the editor published in the Oct. 18 issue of the .

Why might surgery raise the risk of death after a cancer diagnosis?

"It is well-known that all poses some to the patient," Voskoboynik said. "This risk varies depending on the actual surgery involved and on the patient's underlying medical condition and general health. This is due to many factors, including, but not exclusively, the physiological stress that major surgery places on the human body and post-surgical complications."

Although the risk of cardiac death or with low-risk surgery is less than 1 percent, it rises to as much as 5 percent for intermediate-risk procedures and higher rates for high-risk operations, the researchers said.

Voskoboynik cautioned, however, that the overall risk of cardiac death is still very small in recently diagnosed cancer patients. The study design didn't allow the researchers to determine the exact level of risk.

"Our analysis doesn't address this specifically," he said.

Proponents of the stress theory are skeptical of the new report.

Among them is Unnur Valdimarsdottir, an associate professor at the University of Iceland and co-author of a recent Swedish report supporting stress as the trigger of early cancer deaths.

For one thing, she said, her own study found that the risk of cardiac death after diagnosis was especially high for blood and immune system cancers that are rarely treated with surgery.

Her study, released earlier this year, estimated that cancer patients face a six-fold greater risk of dying of cardiac disease in the week after diagnosis compared to people without cancer. The risk was tripled over the four weeks after diagnosis.

Also, Valdimarsdottir said, cancer patients with the poorest prognosis are at highest risk of cardiac death, and their cancer is often too advanced for surgical treatment to make a difference. Finally, suicide rates increased nearly five-fold during the first 12 weeks after diagnosis, "which further supports our earlier interpretation of the role of ."

Determining the true source of these early deaths is important, Valdimarsdottir said.

"We know for sure that the risk of cardiovascular events rises dramatically
following a and the whole clinical community should be
aware of this, and also patients and their families," she said. "The interpretation of
the reasons behind this rise—stress or surgery—is fundamental for the
question of prevention."

Is there a take-home message for patients?

No, said study lead author Voskoboynik. "Our analysis is relevant mainly to investigators studying the potential causes of deaths in with newly diagnosed cancer, particularly in the first few weeks after diagnosis," he said.

"Our research should not have any impact on a patient's decision with regards to having for their , as these procedures may be life-saving," he said.

Explore further: Risk of suicide and fatal heart attack immediately following a cancer diagnosis

More information: For more about cancer, visit the U.S. National Library of Medicine.

Related Stories

Risk of suicide and fatal heart attack immediately following a cancer diagnosis

April 5, 2012
(Medical Xpress) -- People who are diagnosed with cancer have a markedly increased risk of suicide and cardiovascular death during the period immediately after being given the diagnosis. This has been shown in a new study ...

Pre-test genetic counseling increases cancer knowledge for BRCA patients

August 15, 2012
(Medical Xpress) -- Researchers at Moffitt Cancer Center have found that when breast cancer patients are offered pre-test genetic counseling before definitive breast cancer surgery, patients exhibited decreases in distress. ...

Blood test predicts death from heart problems after surgery

July 4, 2012
(Medical Xpress) -- A blood test can predict whether patients are likely to die of a heart attack in the month after surgery, according to an international study involving thousands of patients.

Outpatient surgery patients also at risk for blood clots

April 24, 2012
A University of Michigan Health System study examined who's having outpatient surgery in the U.S. today, and showed 1 in 84 highest-risk patients suffers a dangerous blood clot after surgery.

Recommended for you

New findings explain how UV rays trigger skin cancer

October 18, 2017
Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from ...

Drug yields high response rates for lung cancer patients with harsh mutation

October 18, 2017
A targeted therapy resurrected by the Moon Shots Program at The University of Texas MD Anderson Cancer Center has produced unprecedented response rates among patients with metastatic non-small cell lung cancer that carries ...

Possible new immune therapy target in lung cancer

October 18, 2017
A study from Bern University Hospital in collaboration with the University of Bern shows that so-called perivascular-like cells from lung tumors behave abnormally. They not only inadequately support vascular structures, but ...

Many pelvic tumors in women may have common origin—fallopian tubes

October 17, 2017
Most—and possibly all—ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.

Researchers find novel mechanism of resistance to anti-cancer drugs

October 17, 2017
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors ...

New bowel cancer drug target discovered

October 17, 2017
Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.